iVeena Revenue and Competitors
Estimated Revenue & Valuation
- iVeena's estimated annual revenue is currently $603k per year.
- iVeena's estimated revenue per employee is $100,500
Employee Data
- iVeena has 6 Employees.
- iVeena grew their employee count by 0% last year.
iVeena's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Research & Development | Reveal Email/Phone |
2 | VP Product Development | Reveal Email/Phone |
3 | President, Founder, Board Director | Reveal Email/Phone |
4 | COO and Director | Reveal Email/Phone |
iVeena Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.2M | 46 | 5% | N/A | N/A |
#2 | $17.3M | 86 | 4% | N/A | N/A |
#3 | $20.5M | 102 | -1% | N/A | N/A |
#4 | $7.6M | 38 | -3% | N/A | N/A |
#5 | $14.9M | 74 | 37% | N/A | N/A |
#6 | $10.7M | 53 | -9% | N/A | N/A |
#7 | $6.2M | 31 | 7% | N/A | N/A |
#8 | $6.8M | 34 | 13% | N/A | N/A |
#9 | $5.4M | 27 | -36% | N/A | N/A |
#10 | $305.9M | 1522 | 8% | N/A | N/A |
What Is iVeena?
iVeena is a clinical stage ophthalmology company developing a non-surgical, non-invasive, pharmacologic innovation. This novel disease modifying intervention addresses a significant unmet need in the advancement of corneal diseases and myopic conditions. The company’s lead programs comprise of novel proprietary products; IVMED-80 for keratoconus and IVMED-85 for myopia.
keywords:N/AN/A
Total Funding
6
Number of Employees
$603k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A |
#2 | $0.4M | 6 | 0% | N/A |
#3 | $0.9M | 6 | 0% | N/A |
#4 | $0.4M | 6 | -33% | N/A |
#5 | $0.6M | 6 | 0% | N/A |